Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma

This study has been completed.
Information provided by:
Millennium Pharmaceuticals, Inc. Identifier:
First received: March 30, 2004
Last updated: March 26, 2009
Last verified: March 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: June 2005 (Final data collection date for primary outcome measure)